New Journey(SZ:002219) Zhong Guo Chan Ye Jing Ji Xin Xi Wang·2025-07-25 01:39Core Viewpoint - The news highlights that Yunnan Aierfa Biotechnology Co., Ltd.'s astaxanthin products have been designated as official supplies for the Embassy of Equatorial Guinea in China, marking a significant milestone for China's health industry and demonstrating Aierfa's product strength [1] Group 1: Company Achievements - Aierfa has established itself as a high-tech enterprise focused on the cultivation of Haematococcus pluvialis and the research and development of natural astaxanthin, achieving this recognition through years of research, production, and market development [2] - The company has developed a new product, an 8mg astaxanthin gel candy, utilizing advanced microencapsulation technology to enhance stability and bioavailability, which has been well-received by consumers [4] Group 2: Research and Development - Aierfa's research capabilities are underscored by its R&D investment, which has exceeded 9% of its revenue for the past three years, significantly higher than the industry average, providing a solid financial foundation for technological innovation [6] - The company has formed a robust network of industry-academia-research collaborations with institutions such as the Chinese Academy of Sciences and Shanghai Ocean University, supporting its technological advancements in the astaxanthin field [7] Group 3: Intellectual Property and Standards - Aierfa has developed 128 patents, including one PCT international patent, covering various aspects of Haematococcus pluvialis cultivation, astaxanthin extraction, and product development, establishing a comprehensive patent protection system [9] - The company has actively participated in the formulation of national standards, enhancing its influence in the industry and contributing to the standardization of the astaxanthin sector [9] Group 4: Global Expansion - Aierfa has established a rigorous quality control system and a full-chain certification system, including certifications from the US GMP, CNAS, and various international standards, facilitating its entry into international markets [11] - The company's astaxanthin sales network spans over 30 countries, with an average market share of approximately 35.77% in the global astaxanthin raw material market over the past three years, showcasing its comprehensive industry chain layout [12]